English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative
Raltegravir plus lamivudine is likely to work as PrEP
First year of PrEP in Scotland: more users than expected, few dropouts, few HIV infections
Urine test can provide accurate point-of-care results about PrEP adherence
TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so
People stay on PrEP for 14 months on average in the US, study finds
How many people who have used PrEP get HIV the same year? New York study finds out
Descovy is non-inferior to Truvada for daily PrEP
55% drop in HIV incidence in gay men in England in just two years
